Pearson AD - Search Results

1

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin.

Veal GJ, Griffin MJ, Price E, Parry A, Dick GS, Little MA, Yule SM, Morland B, Estlin EJ, Hale JP, Pearson AD, Welbank H, Boddy AV. Veal GJ, et al. Among authors: pearson ad. Br J Cancer. 2001 Apr 20;84(8):1029-35. doi: 10.1054/bjoc.2001.1723. Br J Cancer. 2001. PMID: 11308249 Free PMC article. Clinical Trial.

2

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.

Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengupta RP, Pearson AD. Jaros E, et al. Among authors: pearson ad. Br J Cancer. 1992 Aug;66(2):373-85. doi: 10.1038/bjc.1992.273. Br J Cancer. 1992. PMID: 1503912 Free PMC article.

3

The influence of age on nephrotoxicity following chemotherapy in children.

Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. Skinner R, et al. Among authors: pearson ad. Br J Cancer Suppl. 1992 Aug;18:S30-5. Br J Cancer Suppl. 1992. PMID: 1503924 Free PMC article. Clinical Trial.

4

Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.

Tasso MJ, Boddy AV, Price L, Wyllie RA, Pearson AD, Idle JR. Tasso MJ, et al. Among authors: pearson ad. Cancer Chemother Pharmacol. 1992;30(3):207-11. doi: 10.1007/BF00686313. Cancer Chemother Pharmacol. 1992. PMID: 1628369

5

The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.

Pearson AD, Amineddine HA, Yule M, Mills S, Long DR, Craft AW, Chessells JM. Pearson AD, et al. Br J Cancer. 1991 Jul;64(1):169-73. doi: 10.1038/bjc.1991.263. Br J Cancer. 1991. PMID: 1854617 Free PMC article. Clinical Trial.

6

Ototoxicity of cisplatinum in children and adolescents.

Skinner R, Pearson AD, Amineddine HA, Mathias DB, Craft AW. Skinner R, et al. Among authors: pearson ad. Br J Cancer. 1990 Jun;61(6):927-31. doi: 10.1038/bjc.1990.208. Br J Cancer. 1990. PMID: 2372498 Free PMC article.

7

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.

Pinkerton CR, Zucker JM, Hartmann O, Pritchard J, Broadbent V, Morris-Jones P, Breatnach F, Craft AE, Pearson AD, Wallendszus KR, et al. Pinkerton CR, et al. Among authors: pearson ad. Br J Cancer. 1990 Aug;62(2):319-23. doi: 10.1038/bjc.1990.286. Br J Cancer. 1990. PMID: 2386751 Free PMC article.

8

Comparison of continuous infusion and bolus administration of ifosfamide in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Among authors: pearson ad. Eur J Cancer. 1995;31A(5):785-90. doi: 10.1016/0959-8049(95)00090-6. Eur J Cancer. 1995. PMID: 7640054

9

The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion.

Boddy AV, Cole M, Pearson AD, Idle JR. Boddy AV, et al. Among authors: pearson ad. Cancer Chemother Pharmacol. 1995;36(1):53-60. doi: 10.1007/BF00685732. Cancer Chemother Pharmacol. 1995. PMID: 7720176

10

Solid alveolar rhabdomyosarcoma with a t(2;13).

Yule SM, Bown N, Malcolm AJ, Reid MM, Pearson AD. Yule SM, et al. Among authors: pearson ad. Cancer Genet Cytogenet. 1995 Apr;80(2):107-9. doi: 10.1016/0165-4608(94)00170-g. Cancer Genet Cytogenet. 1995. PMID: 7736424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

400 results

Search Page

Filters